The report covers forecast and analysis for the therapeutic vaccines market on a global and regional level. The study provides historic data from 2014 along with a forecast for 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the therapeutic vaccines market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the therapeutic vaccines market on a global level.


In order to give the users of this report a comprehensive view on the therapeutic vaccines market, we have to include competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product segments and technology segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new therapy launch, agreements, partnerships, collaborations joint ventures, research development, therapy and regional expansion of major participants involved in the market on the global and regional basis.


The study provides a decisive view on the therapeutic vaccines market by segmenting the market based on therapy, technology, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022. Based on the product the market is segmented into addiction vaccines, autoimmune disease vaccines, infectious disease vaccines and neurological disease vaccines. The technology segment is classified into autologous vaccines and allogeneic vaccines. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America and the Middle East Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for therapeutic vaccines based on the individual segment in all the regions and countries.


Some of the key players in therapeutic vaccines market include Valeant Pharmaceuticals, BioVex, Inc., Inovio Pharmaceuticals, Inc., Immunocellular Therapeutics, Ltd., Agenus Inc., GlaxoSmithKline plc., Pfizer Inc., Novartis AG, Argos Therapeutics, Bavarian Nordic, Transgene, Galena Biopharma and Vaccinogen, Inc. among others.

This report segments the global therapeutic vaccines market as follows:


Global Therapeutic Vaccines Market: Product Segment Analysis

Addiction Vaccines

Autoimmune Disease Vaccines

Infectious Disease Vaccines

Neurological Disease Vaccines

Global Therapeutic Vaccines Market: Technology Segment Analysis

Autologous vaccines

Allogeneic vaccines

Global Therapeutic Vaccines Market: Regional Segment Analysis

North America


U.S.

Europe


UK

France

Germany

Asia Pacific


China

Japan

India

Latin America


Brazil

Middle East and Africa